Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(2.20)
# 2,683
Out of 4,732 analysts
419
Total ratings
38.1%
Success rate
-3.16%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
IPHA Innate Pharma | Reiterates: Buy | $12 | $1.69 | +580.47% | 13 | Jan 17, 2025 | |
ABSI Absci | Reiterates: Buy | $7 | $2.90 | +141.38% | 13 | Jan 17, 2025 | |
NUVL Nuvalent | Reiterates: Buy | $110 | $75.84 | +45.04% | 2 | Jan 17, 2025 | |
LPTX Leap Therapeutics | Reiterates: Buy | $5.5 | $2.55 | +115.69% | 13 | Jan 16, 2025 | |
ITOS iTeos Therapeutics | Reiterates: Buy | $21 | $8.00 | +162.50% | 10 | Jan 16, 2025 | |
VCEL Vericel | Reiterates: Buy | $60 | $59.07 | +1.57% | 17 | Jan 15, 2025 | |
QSI Quantum-Si incorporated | Reiterates: Buy | $5.5 | $2.24 | +145.54% | 6 | Jan 14, 2025 | |
ELEV Elevation Oncology | Reiterates: Buy | $6 | $0.71 | +743.53% | 7 | Jan 14, 2025 | |
EKSO Ekso Bionics Holdings | Reiterates: Buy | $9 | $0.65 | +1,281.43% | 13 | Jan 14, 2025 | |
XFOR X4 Pharmaceuticals | Reiterates: Buy | $1.5 | $0.51 | +195.51% | 13 | Jan 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $14.31 | +53.74% | 11 | Jan 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.71 | +885.92% | 18 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $13.34 | +147.38% | 17 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $17.64 | +41.72% | 17 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $4.89 | +124.95% | 12 | Jan 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $17 | $14.41 | +17.97% | 5 | Jan 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 → $5 | $1.50 | +233.33% | 7 | Dec 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.74 | +1,336.78% | 12 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $15.90 | +57.23% | 12 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $7 | $0.53 | +1,220.51% | 8 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.33 | +1,215.79% | 10 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.15 | +769.57% | 12 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $70 | $40.72 | +71.91% | 11 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.03 | +172.95% | 11 | Nov 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.30 | +2,600.88% | 13 | Nov 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.76 | +81.16% | 2 | Nov 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $10.93 | +147.03% | 5 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.11 | +260.36% | 8 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.21 | - | 2 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.64 | +692.68% | 5 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $20.00 | +100.00% | 4 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $3.09 | +353.07% | 9 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $55.31 | +44.64% | 17 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.17 | +775.58% | 13 | Aug 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $3 → $0.95 | $0.80 | +18.75% | 4 | Aug 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.96 | +78.57% | 2 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $9.12 | +20.61% | 8 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.09 | +547.25% | 1 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.60 | +733.33% | 5 | Mar 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.27 | +175.23% | 1 | Dec 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.80 | - | 2 | Aug 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.00 | - | 12 | May 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.94 | +857.45% | 1 | Feb 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $2.30 | +986.96% | 2 | Jan 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.84 | +171.74% | 1 | Dec 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.24 | +1,542.71% | 1 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $2.62 | +358.02% | 2 | Aug 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.49 | +3,956.80% | 2 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.61 | - | 8 | May 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $1.95 | +4,002.56% | 5 | Feb 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $5.01 | +19.76% | 4 | Jul 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $6.45 | +132.56% | 5 | Nov 9, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $5.33 | +519.14% | 1 | Mar 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $11.57 | -17.89% | 3 | Mar 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $5.64 | +248,272.27% | 1 | Mar 5, 2020 |
Innate Pharma
Jan 17, 2025
Reiterates: Buy
Price Target: $12
Current: $1.69
Upside: +580.47%
Absci
Jan 17, 2025
Reiterates: Buy
Price Target: $7
Current: $2.90
Upside: +141.38%
Nuvalent
Jan 17, 2025
Reiterates: Buy
Price Target: $110
Current: $75.84
Upside: +45.04%
Leap Therapeutics
Jan 16, 2025
Reiterates: Buy
Price Target: $5.5
Current: $2.55
Upside: +115.69%
iTeos Therapeutics
Jan 16, 2025
Reiterates: Buy
Price Target: $21
Current: $8.00
Upside: +162.50%
Vericel
Jan 15, 2025
Reiterates: Buy
Price Target: $60
Current: $59.07
Upside: +1.57%
Quantum-Si incorporated
Jan 14, 2025
Reiterates: Buy
Price Target: $5.5
Current: $2.24
Upside: +145.54%
Elevation Oncology
Jan 14, 2025
Reiterates: Buy
Price Target: $6
Current: $0.71
Upside: +743.53%
Ekso Bionics Holdings
Jan 14, 2025
Reiterates: Buy
Price Target: $9
Current: $0.65
Upside: +1,281.43%
X4 Pharmaceuticals
Jan 14, 2025
Reiterates: Buy
Price Target: $1.5
Current: $0.51
Upside: +195.51%
Jan 14, 2025
Reiterates: Buy
Price Target: $22
Current: $14.31
Upside: +53.74%
Jan 13, 2025
Reiterates: Buy
Price Target: $7
Current: $0.71
Upside: +885.92%
Jan 13, 2025
Reiterates: Buy
Price Target: $33
Current: $13.34
Upside: +147.38%
Jan 10, 2025
Reiterates: Buy
Price Target: $25
Current: $17.64
Upside: +41.72%
Jan 8, 2025
Maintains: Buy
Price Target: $11
Current: $4.89
Upside: +124.95%
Jan 6, 2025
Maintains: Buy
Price Target: $15 → $17
Current: $14.41
Upside: +17.97%
Dec 20, 2024
Reiterates: Buy
Price Target: $7 → $5
Current: $1.50
Upside: +233.33%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $1.74
Upside: +1,336.78%
Dec 18, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $15.90
Upside: +57.23%
Dec 11, 2024
Maintains: Buy
Price Target: $9 → $7
Current: $0.53
Upside: +1,220.51%
Dec 10, 2024
Reiterates: Buy
Price Target: $18
Current: $1.33
Upside: +1,215.79%
Dec 10, 2024
Reiterates: Buy
Price Target: $10
Current: $1.15
Upside: +769.57%
Dec 3, 2024
Maintains: Buy
Price Target: $63 → $70
Current: $40.72
Upside: +71.91%
Nov 29, 2024
Reiterates: Buy
Price Target: $11
Current: $4.03
Upside: +172.95%
Nov 26, 2024
Reiterates: Buy
Price Target: $8
Current: $0.30
Upside: +2,600.88%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $2.76
Upside: +81.16%
Nov 15, 2024
Reiterates: Buy
Price Target: $27
Current: $10.93
Upside: +147.03%
Nov 15, 2024
Reiterates: Buy
Price Target: $4
Current: $1.11
Upside: +260.36%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.21
Upside: -
Nov 13, 2024
Reiterates: Buy
Price Target: $13
Current: $1.64
Upside: +692.68%
Nov 11, 2024
Reiterates: Buy
Price Target: $40
Current: $20.00
Upside: +100.00%
Nov 1, 2024
Reiterates: Buy
Price Target: $14
Current: $3.09
Upside: +353.07%
Oct 31, 2024
Reiterates: Buy
Price Target: $80
Current: $55.31
Upside: +44.64%
Aug 29, 2024
Reiterates: Buy
Price Target: $19
Current: $2.17
Upside: +775.58%
Aug 23, 2024
Downgrades: Neutral
Price Target: $3 → $0.95
Current: $0.80
Upside: +18.75%
Aug 13, 2024
Reiterates: Buy
Price Target: $3.5
Current: $1.96
Upside: +78.57%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $9.12
Upside: +20.61%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $3.09
Upside: +547.25%
Mar 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.60
Upside: +733.33%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $3.27
Upside: +175.23%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.80
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $5.00
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $0.94
Upside: +857.45%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $2.30
Upside: +986.96%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.84
Upside: +171.74%
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $0.24
Upside: +1,542.71%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $2.62
Upside: +358.02%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.49
Upside: +3,956.80%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $17.61
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $1.95
Upside: +4,002.56%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $5.01
Upside: +19.76%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $6.45
Upside: +132.56%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $5.33
Upside: +519.14%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $11.57
Upside: -17.89%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $5.64
Upside: +248,272.27%